Clinical Trial NCT04170023
Trial
Alexion – ACH228-110 (NCT04170023)
Clinical trial ID
NCT04170023
Drug name
ALXN2050
Company:
Alexion
Drug trade name
---
Clinicaltrials.gov
Learn more
Phase of study
2
Current status
Active, not recruiting
Start
12/2019
Substance
---
Research question
Safety and efficiacy ofALXN2050asa monotherapy
Delivery method of drug
Oral
Frequency
---
Clinical trial locations
Canada Italy Korea New Zealand Spain Turkey UK